Posted by Wayne Rhoads on Nov 12th, 2025
Tobam lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 56.5% during the second quarter, Holdings Channel reports. The firm owned 9,584 shares of the company’s stock after selling...
More of this article »